Literature DB >> 24922105

Periodic presumptive treatment for women with prevalent vaginal infections: secondary analysis of data from a randomized controlled trial.

Vernon Mochache1, Raymond Scott McClelland, Jennifer E Balkus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24922105      PMCID： PMC4425269          DOI： 10.1097/OLQ.0000000000000152

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN： 0148-5717            Impact factor:   2.830


× No keyword cloud information.
  9 in total

Review 1.  Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies.

Authors:  Julius Atashili; Charles Poole; Peter M Ndumbe; Adaora A Adimora; Jennifer S Smith
Journal:  AIDS       Date:  2008-07-31       Impact factor: 4.177

Review 2.  The global epidemiology of bacterial vaginosis: a systematic review.

Authors:  Chris Kenyon; Robert Colebunders; Tania Crucitti
Journal:  Am J Obstet Gynecol       Date:  2013-05-06       Impact factor: 8.661

3.  Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis.

Authors:  Jack D Sobel; Daron Ferris; Jane Schwebke; Paul Nyirjesy; Harold C Wiesenfeld; Jeffrey Peipert; David Soper; Suzanne E Ohmit; Sharon L Hillier
Journal:  Am J Obstet Gynecol       Date:  2006-04-21       Impact factor: 8.661

4.  Bacterial vaginosis, gonorrhea, and chlamydial infection among women attending a sexually transmitted disease clinic: a longitudinal analysis of possible causal links.

Authors:  Maria F Gallo; Maurizio Macaluso; Lee Warner; Michael E Fleenor; Edward W Hook; Ilene Brill; Mark A Weaver
Journal:  Ann Epidemiol       Date:  2011-12-20       Impact factor: 3.797

5.  Prevalence and risk factors for vaginal candidiasis among women seeking primary care for genital infections in Dar es Salaam, Tanzania.

Authors:  L A Namkinga; M I N Matee; A K Kivaisi; C Moshiro
Journal:  East Afr Med J       Date:  2005-03

6.  Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection.

Authors:  Rebecca M Brotman; Mark A Klebanoff; Tonja R Nansel; Kai F Yu; William W Andrews; Jun Zhang; Jane R Schwebke
Journal:  J Infect Dis       Date:  2010-11-10       Impact factor: 5.226

Review 7.  Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis.

Authors:  J D Sobel
Journal:  Am J Obstet Gynecol       Date:  1985-08-01       Impact factor: 8.661

8.  Prevalence and incidence of Trichomonas vaginalis infections in women participating in a clinical trial in Durban, South Africa.

Authors:  Sarita Naidoo; Handan Wand
Journal:  Sex Transm Infect       Date:  2013-04-20       Impact factor: 3.519

9.  Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial.

Authors:  R Scott McClelland; Barbra A Richardson; Wisal M Hassan; Vrasha Chohan; Ludo Lavreys; Kishorchandra Mandaliya; James Kiarie; Walter Jaoko; Jeckoniah O Ndinya-Achola; Jared M Baeten; Ann E Kurth; King K Holmes
Journal:  J Infect Dis       Date:  2008-05-15       Impact factor: 5.226
  9 in total
  1 in total

Review 1.  Lessons from Suppressive Therapy and Periodic Presumptive Treatment for Bacterial Vaginosis.

Authors:  Jennifer E Balkus; Kayla A Carter; R Scott McClelland
Journal:  Curr Infect Dis Rep       Date:  2019-08-31       Impact factor: 3.725
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.